These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 16546489)

  • 1. DNA-based window of opportunity for curative pre-emptive therapy of hereditary medullary thyroid cancer.
    Machens A; Dralle H
    Surgery; 2006 Mar; 139(3):279-82. PubMed ID: 16546489
    [No Abstract]   [Full Text] [Related]  

  • 2. Invited commentary: medullary thyroid cancer: the importance of RET testing.
    Evans DB; Shapiro SE; Cote GJ
    Surgery; 2007 Jan; 141(1):96-9. PubMed ID: 17188173
    [No Abstract]   [Full Text] [Related]  

  • 3. Very early manifestation of hereditary medullary thyroid cancer in carriers of intracellular-domain RET mutations.
    Machens A; Dralle H
    J Pediatr Surg; 2007 Jun; 42(6):1153; author reply 1154. PubMed ID: 17560241
    [No Abstract]   [Full Text] [Related]  

  • 4. Prophylactic thyroidectomy in RET carriers at risk for hereditary medullary thyroid cancer.
    Machens A; Dralle H
    Thyroid; 2009 Jun; 19(6):551-4. PubMed ID: 19499987
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of RET codonic mutations in the surgical management of medullary thyroid carcinoma in pediatric age multiple endocrine neoplasm type 2 syndromes.
    Spinelli C; Di Giacomo M; Costanzo S; Elisei R; Miccoli P
    J Pediatr Surg; 2010 Aug; 45(8):1610-6. PubMed ID: 20713208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial medullary carcinoma prevention, risk evaluation, and RET in children of families with MEN2.
    Moore SW; Appfelstaedt J; Zaahl MG
    J Pediatr Surg; 2007 Feb; 42(2):326-32. PubMed ID: 17270543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New presentation of familial medullary thyroid carcinoma in 87-year-old patient with high-risk RET proto-oncogene codon 620 mutation.
    Jaggard MK; MacRae C; Ifeacho S; Robinson S; Tolley NS
    J Laryngol Otol; 2009 Jul; 123(7):796-800. PubMed ID: 18771606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The RET gene and medullary thyroid cancer: from mutations to the planning of therapy].
    Conzo G; Ruggiero R; Palazzo A; Della Pietra C; Stanzione F; Livrea A; Docimo G
    Chir Ital; 2009; 61(5-6):531-8. PubMed ID: 20380254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tumor dormancy of hereditary medullary thyroid carcinoma and RET gene mutations].
    Yü Y; Gao M; Zhang F
    Zhonghua Zhong Liu Za Zhi; 2008 Jul; 30(7):532-3. PubMed ID: 19062722
    [No Abstract]   [Full Text] [Related]  

  • 10. Current approaches to medullary thyroid carcinoma, sporadic and familial.
    Fialkowski EA; Moley JF
    J Surg Oncol; 2006 Dec; 94(8):737-47. PubMed ID: 17131404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Management of multiple endocrine neoplasia syndrome type 2 families in association with rare germline mutations of the RET proto-oncogene].
    Fitze G; Saeger HD; Roesner D; Schackert HK
    Klin Padiatr; 2004; 216(5):270-6. PubMed ID: 15455293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations.
    Learoyd DL; Gosnell J; Elston MS; Saurine TJ; Richardson AL; Delbridge LW; Aglen JV; Robinson BG
    Clin Endocrinol (Oxf); 2005 Dec; 63(6):636-41. PubMed ID: 16343097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early malignant progression of hereditary medullary thyroid cancer.
    Machens A; Niccoli-Sire P; Hoegel J; Frank-Raue K; van Vroonhoven TJ; Roeher HD; Wahl RA; Lamesch P; Raue F; Conte-Devolx B; Dralle H;
    N Engl J Med; 2003 Oct; 349(16):1517-25. PubMed ID: 14561794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Y791F RET mutation and early onset of medullary thyroid carcinoma in a Brazilian kindred: evaluation of phenotype-modifying effect of germline variants.
    Tamanaha R; Camacho CP; Ikejiri ES; Maciel RM; Cerutti JM
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):806-8. PubMed ID: 17610518
    [No Abstract]   [Full Text] [Related]  

  • 15. Current management of medullary thyroid cancer.
    Sippel RS; Kunnimalaiyaan M; Chen H
    Oncologist; 2008 May; 13(5):539-47. PubMed ID: 18515739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mutations of ret-proto-oncogene in thyroid medullary carcinoma].
    Frank-Raue K; Höppner W; Buhr H; Herfarth C; Ziegler R; Raue F
    Dtsch Med Wochenschr; 1997 Feb; 122(6):143-9. PubMed ID: 9081799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prophylactic thyroidectomy in children who are carriers of a multiple endocrine neoplasia type 2 mutation: description of 20 cases and recommendations based on the literature].
    de Groot JW; Links TP; Rouwe CW; van der Wal JE; Hofstra RM; Plukker JT
    Ned Tijdschr Geneeskd; 2006 Feb; 150(6):311-8. PubMed ID: 16503023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The treatment of medullary thyroid cancer].
    Fujita T; Fujimori M
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1627-31. PubMed ID: 19838021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous medullary and papillary thyroid carcinomas in carriers of the V804M RET germline mutation-a spurious association?
    Machens A; Dralle H
    Surgery; 2010 Jun; 147(6):895-6; author reply 896-7. PubMed ID: 20494215
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of medullary thyroid carcinoma.
    Jiménez C; Hu MI; Gagel RF
    Endocrinol Metab Clin North Am; 2008 Jun; 37(2):481-96, x-xi. PubMed ID: 18502338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.